Advisor Group, Inc. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 1.2%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q4 2019$12,000
+9.1%
1000.0%0.00%
Q3 2019$11,000
+10.0%
1000.0%0.00%
Q2 2019$10,000
+11.1%
1000.0%0.00%
Q1 2019$9,000
-10.0%
100
-23.1%
0.00%
Q4 2018$10,000
+25.0%
130
+30.0%
0.00%
Q3 2018$8,000
-20.0%
1000.0%0.00%
Q2 2018$10,000
-9.1%
100
-30.1%
0.00%
Q1 2018$11,000
+10.0%
143
+15.3%
0.00%
Q4 2017$10,0000.0%124
+6.9%
0.00%
Q3 2017$10,0001160.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders